These data reveal that patients with CHD suffering from HT or HT + T2DM display elevated levels of markers of low-grade inflammation, also linked to the CD40L–CD40 co-stimulatory dyad. This evidence concerns the gene CD40LG and type 2 diabetes mellitus.